OneSource

Executive Summary

OneSource is a leading Indian specialty pharma CDMO providing end-to-end development and manufacturing services for drug-device combinations, sterile injectables, biologics, and soft gelatin capsules. With over 30 years of experience and GMP-approved facilities, the company serves clients from early-stage formulation through commercial-scale production, focusing on oncology and advanced drug delivery. Its integrated offerings and regulatory expertise position it as a reliable partner for complex therapies. The company has grown to over 1,000 employees and operates out of Ahmedabad, India, targeting both domestic and international markets. OneSource's ability to handle high-potency compounds and combination products differentiates it in the competitive CDMO landscape.

Upcoming Catalysts (preview)

• Q3 2026Completion of new sterile injectables facility expansion75% success
• Q4 2026Strategic partnership with a top-20 pharma for oncology product development40% success
• TBDFDA approval for a client's oncology drug manufactured by OneSource60% success